Creon delayed-release capsules available for exocrine pancreatic insufficiency - MPR
Links shared publicly online about this topic.
- 1,914total visits
Creon delayed-release capsules available for exocrine pancreatic insufficiency - MPR
empr.com —
Solvay Pharmaceuticals has made available Creon (pancrelipase) delayed-release capsules, a zero-overfill pancreatic enzyme product that targets 100% of the lipase amount indicated on the product labeling.
View full resource at empr.com
Tags: Pancreatic Disease, Pharma, Solvay
Most Recently Shared on July 7, 2009 at 9:48 pm By:
MPR News: Creon delayed-release capsules available for exocrine pancreatic insufficiency: Solvay Pharma.. http://tinyurl.com/mzjwfn
Abbott Receives FDA Approval For CREON® (Pancrelipase) Infant-Specific Dosage For Patients With Exocrine Pancreatic Insufficiency
medicalnewstoday.com — “Abbott (NYSE: ABT) announced that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON® (pancrelipase) Delayed-Release Capsules to treat exocrine pancreati” View full resource at medicalnewstoday.com
Most Recently Shared on June 16, 2011 at 7:05 am By:
MNT Cystic Fibrosis Health News
Abbott Receives FDA Approval For CREON® (Pancrelipase) Infant-Specific Dosage For Patients With Exocrine Pancreati... http://mnt.to/3XfN
Advertisement
